Teladoc Health (TDOC) Gross Margin (2014 - 2026)

Teladoc Health has disclosed Gross Margin across 13 years of filings, most recently posting 91.65% for Q1 2026.

• Gross Margin for Q1 2026 came in at 91.65%, up 2292.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 75.1% (up 2068.0% YoY), and the FY2025 annual result was 69.5%, down 126.0% from the prior year.
• Gross Margin came in at 91.65% for Q1 2026 at Teladoc Health, up from 69.32% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 151.43% in Q4 2022 to a low of 6.48% in Q4 2024.
• The 5-year median for Gross Margin is 71.94% (2024), against an average of 76.14%.
• Across the five-year window, Gross Margin soared 13424 bps in 2022 and plunged 14222 bps in 2023, its largest moves.
• Teladoc Health's Gross Margin stood at 151.43% in 2022, then sank by 94 bps to 9.21% in 2023, then fell by 30 bps to 6.48% in 2024, then soared by 970 bps to 69.32% in 2025, then jumped by 32 bps to 91.65% in 2026.
• The last three Gross Margin figures came in at 91.65% (Q1 2026), 69.32% (Q4 2025), and 70.12% (Q3 2025), per Business Quant data.